Atnahs Pharma Denmark ApS: Financial statements 2019
CVR: 36699051
Source: annual report 2019, Danish Business Authority
01/04/2018 – 31/03/2019
Atnahs Pharma Denmark ApS (CVR 36699051) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 778,878 and a net result of DKK -1,052,467 compared with DKK -1,858,350 the year before. Equity in the 2019 report amounted to DKK -2,361,962.
- Gross Profit
- DKK 778,878
- Profit/Loss
- DKK -1,052,467
- Equity
- DKK -2,361,962
- Total Assets
- DKK 1,220,128
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 779 t. | -1.1 mio. | -2.4 mio. | - |
| 2018 | - | -1.4 mio. | -1.9 mio. | -1.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of August 7, 2019, Svend Aage Johansen has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Neeshe Bhikhubhai Williams has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Rishi Bhikhu has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Alastair Thomas Badgett Hay has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Dipen Vijaykumar Patel has left the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Mark John Cotterill has left the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Mark John Cotterill has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Svend Aage Johansen has left the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Amit Vijaykumar Patel is registered as director of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Svend Aage Johansen has stepped down as director of Atnahs Pharma Denmark ApS.
About Atnahs Pharma Denmark ApS
Atnahs Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Pharmamentum ApS. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported revenue of EUR 52,583,756 and a net result of EUR 12,487 compared with DKK 47,843 the year before. Equity in the 2026 report amounted to EUR 2,094,136.